Insider trades
Brad Hively, Director of Starling Oncology STLN, has filed 4 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $50.3K. The latest trade was on 25/12/15.
Brad Hively
Director
- Company
- Starling Oncology STLN
- First filing
- 23/03/21
- Trades
- 35 trades
- Buys / sales
- 4 / 6
- 12-month net buying
- −$50.3K
- Last trade
- 25/12/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/12/15 | 25/12/16 | 13,333 sh | $3.77 | $50,265.41 | −1.9% | |
| Open-market sale | 25/08/19 | 25/08/21 | 20,221 sh | $4.06 | $82,097.26 | −3.1% | |
STLN | Open-market sale | 25/06/03 | 25/06/05 | 1,976,137 sh2 trades | $2.87avg. | $5,671,513.19 | −76.6% |
| Open-market buyAmendment | 25/03/26 | 25/04/28 | 45,280 sh | $1.04 | $47,091.2 | +6.8% | |
| Open-market buy | 25/03/26 | 25/03/28 | 9,056 sh | $1.04 | $9,418.24 | +1.4% | |
STLN | Open-market buy | 24/11/26–24/12/02 | 24/12/02 | 300,000 sh2 trades | $0.17avg. | $50,000 | +81.8% |
| Open-market sale | 23/11/17 | 23/11/21 | 25,000 sh | $2.24 | $56,000 | −3.5% | |
| Open-market sale | 23/11/13 | 23/11/15 | 47,000 sh | $2.52 | $118,440 | −6.1% |